Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Intuitive Surgical
ISRG
$131B
| $30.4M | 0.01% |
61,398
-87,342
| -59% | -$48.3M |
|
1377
CALL
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$194M
| $30.3M | 0.01% |
872,900
-143,200
| -14% | -$5.39M |
|
1378
PG&E
PCG
$40.4B
| $30.3M | 0.01% |
1,764,458
+98,853
| +6% | +$1.64M |
|
1379
PUT
Corning
GLW
$127B
| $30.3M | 0.01% |
662,100
+359,100
| +119% | +$17.7M |
|
1380
American International
AIG
$39.9B
| $30.3M | 0.01% |
348,113
-148,081
| -30% | -$11.5M |
|
|
VRNA
1381
CALL
DELISTED
Verona Pharma
VRNA
| $30.2M | 0.01% |
476,200
+255,600
| +116% | +$15.3M |
|
|
SCHW
1382
Charles Schwab
SCHW
$194B
| $30.2M | 0.01% |
385,388
-259,443
| -40% | -$20.4M |
|
1383
CALL
M&T Bank
MTB
$34.7B
| $30.1M | 0.01% |
168,600
+23,500
| +16% | +$4.46M |
|
|
API
1384
Agora
API
$348M
| $30.1M | 0.01% |
7,484,011
+100
| +0% | +$522 |
|
1385
CAVA Group
CAVA
$8.09B
| $30.1M | 0.01% |
347,882
+196,228
| +129% | +$21.3M |
|
1386
Cognizant
CTSH
$28.4B
| $30.1M | 0.01% |
392,921
-75,429
| -16% | -$6.14M |
|
1387
KraneShares CSI China Internet ETF
KWEB
$5.22B
| $30M | 0.01% |
860,637
-1,345,275
| -61% | -$44.6M |
|
1388
CALL
ProShares UltraPro S&P 500
UPRO
$5.5B
| $30M | 0.01% |
406,500
-84,800
| -17% | -$7.45M |
|
1389
CALL
FMC
FMC
$1.4B
| $30M | 0.01% |
711,800
+222,300
| +45% | +$9.87M |
|
1390
PepsiCo
PEP
$194B
| $30M | 0.01% |
200,018
-469,956
| -70% | -$69.9M |
|
1391
PUT
VanEck Pharmaceutical ETF
PPH
$1.03B
| $30M | 0.01% |
328,900
+325,300
| +9,036% | +$29.3M |
|
1392
PUT
T. Rowe Price
TROW
$24.1B
| $29.9M | 0.01% |
325,800
+161,000
| +98% | +$17M |
|
1393
CALL
Global X Silver Miners ETF NEW
SIL
$5.57B
| $29.9M | 0.01% |
758,000
+611,700
| +418% | +$22M |
|
1394
PUT
Tenet Healthcare
THC
$21.9B
| $29.9M | 0.01% |
222,200
-104,700
| -32% | -$13.8M |
|
1395
Microchip Technology
MCHP
$39.9B
| $29.8M | 0.01% |
615,835
+117,875
| +24% | +$6.57M |
|
1396
CALL
Five Below
FIVE
$14.3B
| $29.8M | 0.01% |
397,400
-150,800
| -28% | -$13.3M |
|
1397
PUT
Bunge Global
BG
$21.5B
| $29.7M | 0.01% |
388,400
+163,300
| +73% | +$12.2M |
|
1398
CALL
MP Materials
MP
$10.7B
| $29.7M | 0.01% |
1,215,100
+721,800
| +146% | +$16.8M |
|
1399
PUT
Valaris
VAL
$5.95B
| $29.6M | 0.01% |
754,600
+420,100
| +126% | +$18M |
|
1400
CALL
Yum China
YUMC
$16.6B
| $29.6M | 0.01% |
567,800
-63,800
| -10% | -$3.06M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.